{
  "actions": [
    {
      "acted_at": "2019-12-12T12:21:05-05:00",
      "action_code": "H32111",
      "how": "by voice vote",
      "references": [],
      "result": "pass",
      "text": "On agreeing to the Finkenauer amendment (A009) Agreed to by voice vote.",
      "type": "vote",
      "vote_type": "vote",
      "where": "h"
    },
    {
      "acted_at": "2019-12-12T12:13:09-05:00",
      "action_code": "H3A100",
      "references": [
        {
          "reference": "CR H10214-10215",
          "type": "consideration"
        },
        {
          "reference": "CR H10214",
          "type": "text"
        }
      ],
      "text": "Amendment (A009) offered by Ms. Finkenauer.",
      "type": "action"
    },
    {
      "acted_at": "2019-12-12T12:13:09-05:00",
      "action_code": "71500",
      "references": [],
      "text": "House amendment offered/reported by: Amendment (A009) offered by Ms. Finkenauer.",
      "type": "action"
    },
    {
      "acted_at": "2019-12-12T12:21:05-05:00",
      "action_code": "72000",
      "references": [],
      "text": "House amendment agreed to: On agreeing to the Finkenauer amendment (A009) Agreed to by voice vote.",
      "type": "action"
    },
    {
      "acted_at": "2019-12-12T12:21:05-05:00",
      "action_code": "76000",
      "references": [],
      "text": "Amendment agreed to Committee of the Whole",
      "type": "action"
    },
    {
      "acted_at": "2019-12-12",
      "action_code": "71000",
      "references": [],
      "text": "House amendment offered",
      "type": "action"
    }
  ],
  "amendment_id": "hamdt719-116",
  "amendment_type": "hamdt",
  "amends_amendment": null,
  "amends_bill": {
    "bill_id": "hr3-116",
    "bill_type": "hr",
    "congress": 116,
    "number": 3
  },
  "amends_treaty": null,
  "chamber": "h",
  "congress": "116",
  "description": "An amendment numbered 9 printed in Part B of House Report 116-334 to require drug companies to disclose truthful and non-misleading pricing information about prescription drugs and biological products when they advertise these products directly to consumers.",
  "introduced_at": "2019-12-12",
  "number": 719,
  "purpose": "An amendment numbered 9 printed in Part B of House Report 116-334 to require drug companies to disclose truthful and non-misleading pricing information about prescription drugs and biological products when they advertise these products directly to consumers.",
  "sponsor": {
    "bioguide_id": "F000467",
    "district": "1",
    "name": "Finkenauer, Abby",
    "state": "IA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "pass",
  "status_at": "2019-12-12T12:21:05-05:00",
  "updated_at": "2022-02-08T23:01:28Z"
}